1.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

2.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

3.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

4.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

5.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

6.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

7.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

8.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

9.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

1.

Origin and characteristics of clonally related isolates.

2.

Origin and characteristics of clonally related isolates.

3.

Origin and characteristics of clonally related isolates.

4.

Origin and characteristics of clonally related isolates.

5.

Origin and characteristics of clonally related isolates.

6.

Origin and characteristics of clonally related isolates.

7.

Origin and characteristics of clonally related isolates.

8.

Origin and characteristics of clonally related isolates.

9.

Origin and characteristics of clonally related isolates.

1.

Fig 1 -

2.

Fig 1 -

3.

Fig 1 -

4.

Fig 1 -

5.

Fig 1 -

6.

Fig 1 -

7.

Fig 1 -

8.

Fig 1 -

9.

Fig 1 -

1.

Sankey diagram of the origin and genetic context of mcr -genes.

2.

Sankey diagram of the origin and genetic context of mcr -genes.

3.

Sankey diagram of the origin and genetic context of mcr -genes.

4.

Sankey diagram of the origin and genetic context of mcr -genes.

5.

Sankey diagram of the origin and genetic context of mcr -genes.

6.

Sankey diagram of the origin and genetic context of mcr -genes.

7.

Sankey diagram of the origin and genetic context of mcr -genes.

8.

Sankey diagram of the origin and genetic context of mcr -genes.

9.

Sankey diagram of the origin and genetic context of mcr -genes.

1.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

2.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

3.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

4.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

5.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

6.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

7.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

8.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

9.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

1.

Fig 4 -

2.

Fig 4 -

3.

Fig 4 -

4.

Fig 4 -

5.

Fig 4 -

6.

Fig 4 -

7.

Fig 4 -

8.

Fig 4 -

9.

Fig 4 -

1.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

2.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

3.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

4.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

5.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

6.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

7.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

8.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

9.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

1.

Clinical acute viral hepatitis encountered by Belgian general practitioners

2.

Clinical acute viral hepatitis encountered by Belgian general practitioners

3.

Clinical acute viral hepatitis encountered by Belgian general practitioners

4.

Clinical acute viral hepatitis encountered by Belgian general practitioners

1.

Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities

2.

Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities

3.

Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities

4.

Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities

1.

Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015–20: a surveillance study

2.

Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015–20: a surveillance study

3.

Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015–20: a surveillance study

4.

Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015–20: a surveillance study